Evidence map›Paper›PMID 37035581›Full record

ReviewCancer research communications2023

Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer.

Jasleen K Badesha, Marilyn Zhou, Arif A Arif, Sharlene Gill, Caroline Speers, Michael Peacock, Mary A De Vera, Heather C Stuart, Carl J Brown, Fergal Donellan and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancer research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jasleen K BadeshaBC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0002-1123-4924
Marilyn ZhouBC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0002-3230-3386
Arif A ArifBC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0001-7364-7866
Sharlene GillBC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0003-3306-3617
Caroline SpeersBC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0003-2361-4681
Michael PeacockBC Cancer, Vancouver, British Columbia, Canada.ORCID 0009-0005-7212-4891
Mary A De VeraThe University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-2205-2683
Heather C StuartThe University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0003-2806-9184
Carl J BrownThe University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-5368-3541
Fergal DonellanThe University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-9428-0864
Jonathan M LoreeBC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0001-8189-2132
BC Cancer Agency · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preoperative radiotherapy for early-stage rectal cancer has risks and benefits that may impact treatment choice in young patients. We reviewed radiotherapy use and outcomes for rectal cancer by age. Patients with early-stage rectal cancer in the Canadian province of British Columbia from 2002 to 2016 were identified ( Significance: This population-based study suggests younger patients are more likely to receive chemoradiotherapy, potentially due to higher stage at diagnosis, and response is comparable by age.

Indexed as

Neoadjuvant TherapyRectal NeoplasmsAgedBritish ColumbiaChemoradiotherapyHumansMiddle AgedNeoplasm Recurrence, Local

Identifiers

PMID37035581
PMCPMC10078624
OpenAlexW4323353330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.